Yosuke Hirasawa

571 total citations
30 papers, 357 citations indexed

About

Yosuke Hirasawa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Yosuke Hirasawa has authored 30 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 10 papers in Surgery. Recurrent topics in Yosuke Hirasawa's work include Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (10 papers) and Bladder and Urothelial Cancer Treatments (9 papers). Yosuke Hirasawa is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (10 papers) and Bladder and Urothelial Cancer Treatments (9 papers). Yosuke Hirasawa collaborates with scholars based in Japan and United States. Yosuke Hirasawa's co-authors include Yoshio Ohno, Tatsuo Gondo, Jun Nakashima, Masaaki Tachibana, Makoto Ohori, Kazunori Namiki, Yoshihiro Nakagami, Toru Sugihara, Yutaka Horiguchi and Yuji Kato and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Surgical Oncology.

In The Last Decade

Yosuke Hirasawa

24 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yosuke Hirasawa Japan	12	160	144	107	100	72	30	357
C. Lebâcle France	12	185 1.2×	227 1.6×	74 0.7×	63 0.6×	82 1.1×	47	408
Yuya Nakamura Japan	10	86 0.5×	120 0.8×	179 1.7×	15 0.1×	31 0.4×	43	305
Hyeong Dong Yuk South Korea	12	126 0.8×	176 1.2×	97 0.9×	45 0.5×	16 0.2×	52	349
Marja Hyöty Finland	13	74 0.5×	280 1.9×	232 2.2×	8 0.1×	42 0.6×	31	430
Akiyoshi Seshimo Japan	11	185 1.2×	127 0.9×	119 1.1×	7 0.1×	24 0.3×	42	343
Kalen Rimar United States	7	190 1.2×	140 1.0×	71 0.7×	15 0.1×	8 0.1×	9	322
N. Bissada United States	8	125 0.8×	85 0.6×	45 0.4×	52 0.5×	31 0.4×	27	299
Chiara Re Italy	9	133 0.8×	87 0.6×	40 0.4×	12 0.1×	8 0.1×	37	235
Atiqullah Aziz Germany	15	116 0.7×	382 2.7×	130 1.2×	132 1.3×	6 0.1×	30	474
Sacit Nuri Görgel Türkiye	10	78 0.5×	139 1.0×	75 0.7×	90 0.9×	36 0.5×	42	277

Countries citing papers authored by Yosuke Hirasawa

Since Specialization

Citations

This map shows the geographic impact of Yosuke Hirasawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yosuke Hirasawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yosuke Hirasawa more than expected).

Fields of papers citing papers by Yosuke Hirasawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yosuke Hirasawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yosuke Hirasawa. The network helps show where Yosuke Hirasawa may publish in the future.

Co-authorship network of co-authors of Yosuke Hirasawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yosuke Hirasawa. A scholar is included among the top collaborators of Yosuke Hirasawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yosuke Hirasawa. Yosuke Hirasawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamamoto, Yutaka, Kiyoshi Takahara, Takuya Tsujino, et al.. (2025). Prognostic Impact of Initial Prostate‐Specific Antigen in Metastatic Hormone‐Sensitive Prostate Cancer Patients With Extensive Bone Metastases Under Androgen Receptor Signaling Inhibitor. The Prostate. 85(14). 1307–1314.

Takahara, Kiyoshi, Wataru Fukuokaya, Keiichiro Mori, et al.. (2025). Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study. International Journal of Urology. 32(11). 1677–1685.

Hashimoto, Mamoru, Kohei Taniguchi, Takafumi Minami, et al.. (2025). Upper urinary tract urothelial carcinoma patients show better overall response rate than bladder cancer patients during enfortumab vedotin treatment following pembrolizumab. Translational Andrology and Urology. 14(8). 2279–2288.

Hirasawa, Yosuke, Atsushi Satomura, Mitsuyoshi Utsugi, et al.. (2025). Urinary microRNAs as Prognostic Biomarkers for Predicting the Efficacy of Immune Checkpoint Inhibitors in Patients with Urothelial Carcinoma. Cancers. 17(16). 2640–2640.

Hashimoto, Mamoru, Kohei Taniguchi, Takafumi Minami, et al.. (2025). Cancer-induced Pain Is Associated With Poor Overall Survival of Urothelial Carcinoma Patients Treated With Enfortumab Vedotin. In Vivo. 39(3). 1533–1539. 1 indexed citations

Hirasawa, Yosuke, Takeshi Hashimoto, Wataru Fukuokaya, et al.. (2024). Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan. Journal of Cancer Research and Clinical Oncology. 150(4). 182–182. 12 indexed citations

Hirasawa, Yosuke, Takeshi Kashima, Takeshi Hashimoto, et al.. (2024). Comparison of Postoperative Stress Urinary Incontinence between Anteroposterior Dissection and Modified Gilling Method in Holmium Laser Enucleation of the Prostate.. PubMed. 21(2). 133–139. 1 indexed citations

Hashimoto, Takeshi, Yosuke Hirasawa, Naoya Satake, et al.. (2023). Clinical value of minimum apparent diffusion coefficient for prediction of clinically significant prostate cancer in the transition zone. International Journal of Clinical Oncology. 28(5). 716–723. 1 indexed citations

Fukuokaya, Wataru, Kazumasa Komura, Taizo Uchimoto, et al.. (2023). Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study. International Journal of Urology. 31(4). 342–347. 16 indexed citations

10.

Dorff, Tanya B., Yosuke Hirasawa, Jared D. Acoba, et al.. (2021). Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T. Journal for ImmunoTherapy of Cancer. 9(8). e002931–e002931. 28 indexed citations

11.

Hirasawa, Yosuke, Ian Pagano, Jeffrey Huang, et al.. (2021). Case Study of Noni Extract in Men with Very Low-Risk or Low-Risk Prostate Cancer.. PubMed. 80(10). 242–250. 2 indexed citations

12.

Hirasawa, Yosuke, Ian Pagano, Runpu Chen, et al.. (2021). Diagnostic performance of Oncuria™, a urinalysis test for bladder cancer. Journal of Translational Medicine. 19(1). 141–141. 36 indexed citations

13.

MIMA, Takashi, Makoto Ohori, Yosuke Hirasawa, et al.. (2018). Salvage radiation therapy for prostate cancer patients after prostatectomy. Japanese Journal of Clinical Oncology. 49(3). 281–286. 2 indexed citations

14.

Hirasawa, Yosuke, Makoto Ohori, Toru Sugihara, et al.. (2017). No clinical significance of the time interval between biopsy and robotic-assisted radical prostatectomy for patients with clinically localized prostate cancer on biochemical recurrence: a propensity score matching analysis. Japanese Journal of Clinical Oncology. 47(11). 1083–1089. 5 indexed citations

15.

Hirasawa, Yosuke, et al.. (2017). Transurethral Enucleation with Bipolar for Benign Prostatic Hyperplasia: 2-Year Outcomes and the Learning Curve of a Single Surgeon's Experience of 603 Consecutive Patients. Journal of Endourology. 31(7). 679–685. 23 indexed citations

16.

Hirasawa, Yosuke, Kunihiko Yoshioka, Yasutomo Nasu, et al.. (2017). Impact of Surgeon and Hospital Volume on the Safety of Robot-Assisted Radical Prostatectomy: A Multi-Institutional Study Based on a National Database. Urologia Internationalis. 98(3). 334–342. 11 indexed citations

17.

Hirasawa, Yosuke, Takashi MIMA, Toru Sugihara, et al.. (2016). A Case of Primary Small-Cell Carcinoma of the Bladder. Case Reports in Oncology. 9(3). 574–579. 1 indexed citations

18.

Hirasawa, Yosuke, Yoshio Ohno, Jun Nakashima, et al.. (2015). Impact of a preoperatively estimated prostate volume using transrectal ultrasonography on surgical and oncological outcomes in a single surgeon’s experience with robot-assisted radical prostatectomy. Surgical Endoscopy. 30(9). 3702–3708. 12 indexed citations

19.

Hirasawa, Yosuke, Akira Miyajima, Kazutoshi Miyashita, et al.. (2014). Laparoendoscopic single-site adrenalectomy versus conventional laparoscopic adrenalectomy: a comparison of surgical outcomes and an analysis of a single surgeon’s learning curve. Surgical Endoscopy. 28(10). 2911–2919. 19 indexed citations

20.

Hirasawa, Yosuke, Hiroki Ide, Yota Yasumizu, et al.. (2012). Comparison of transurethral enucleation with bipolar and transurethral resection in saline for managing benign prostatic hyperplasia. British Journal of Urology. 110(11c). E864–9. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact